Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2017

Ausgabe 3/2017

Inhaltsverzeichnis ( 34 Artikel )

05.07.2017 | Editorial | Ausgabe 3/2017

Whither surgical quality assurance of breast cancer surgery (surgical margins and local recurrence) after paterson

N. J. Bundred, J. Thomas, J. M. J. Dixon

04.07.2017 | Review | Ausgabe 3/2017

Preoperative paravertebral blocks for the management of acute pain following mastectomy: a cost-effectiveness analysis

Anaeze C. Offodile II, Clifford C. Sheckter, Austin Tucker, Anna Watzker, Kevin Ottino, Martin Zammert, William V. Padula

08.07.2017 | Review | Ausgabe 3/2017 Open Access

Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer

Xavier Ghislain Léon Victor Pouwels, Bram L. T. Ramaekers, Manuela A. Joore

08.07.2017 | Review | Ausgabe 3/2017

Predictive factors on outcomes in metaplastic breast cancer

C. Marc Leyrer, Camille A. Berriochoa, Shree Agrawal, Alana Donaldson, Benjamin C. Calhoun, Chirag Shah, Robyn Stewart, Halle C. F. Moore, Rahul D. Tendulkar

28.06.2017 | Preclinical study | Ausgabe 3/2017

A step-by-step oncoplastic breast conservation surgical atlas of reproducible dissection techniques and anatomically ideal incision placement

Sunny D. Mitchell

05.07.2017 | Preclinical study | Ausgabe 3/2017

Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1

Marine Geoffroy, Alexandra Kleinclauss, Stéphanie Grandemange, Sébastien Hupont, Michel Boisbrun, Stéphane Flament, Isabelle Grillier-Vuissoz, Sandra Kuntz

31.07.2017 | Erratum | Ausgabe 3/2017

Erratum to: Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1

Marine Geoffroy, Alexandra Kleinclauss, Stéphanie Grandemange, Sébastien Hupont, Michel Boisbrun, Stéphane Flament, Isabelle Grillier-Vuissoz, Sandra Kuntz

10.07.2017 | Preclinical study | Ausgabe 3/2017 Open Access

New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth

Heba Alshaker, Qi Wang, Shyam Srivats, Yimin Chao, Colin Cooper, Dmitri Pchejetski

23.06.2017 | Clinical trial | Ausgabe 3/2017

Does biomarker information impact breast cancer patients’ preferences and physician recommendation for adjuvant chemotherapy?

Ann H. Partridge, Karen Sepucha, Anne O’Neill, Kathy D. Miller, Emily Baker, Chau T. Dang, Donald W. Northfelt, George W. Sledge, Bryan P. Schneider

27.06.2017 | Clinical trial | Ausgabe 3/2017 Open Access

Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure

Nicole C. Verheuvel, Adri C. Voogd, Vivianne C. G. Tjan-Heijnen, S. Siesling, Rudi M. H. Roumen

28.06.2017 | Clinical trial | Ausgabe 3/2017

Mammographic breast density decreases after bariatric surgery

Austin D. Williams, Alycia So, Marie Synnestvedt, Colleen M. Tewksbury, Despina Kontos, Meng-Kang Hsiehm, Lauren Pantalone, Emily F. Conant, Mitchell Schnall, Kristoffel Dumon, Noel Williams, Julia Tchou

29.06.2017 | Clinical trial | Ausgabe 3/2017 Open Access

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

Ulrike Nitz, Oleg Gluz, Matthias Christgen, Ronald E. Kates, Michael Clemens, Wolfram Malter, Benno Nuding, Bahriye Aktas, Sherko Kuemmel, Toralf Reimer, Andrea Stefek, Fatemeh Lorenz-Salehi, Petra Krabisch, Marianne Just, Doris Augustin, Cornelia Liedtke, Calvin Chao, Steven Shak, Rachel Wuerstlein, Hans H. Kreipe, Nadia Harbeck

03.07.2017 | Clinical Trial | Ausgabe 3/2017

A pilot study of cabergoline for the treatment of metastatic breast cancer

Ricardo Costa, C. A. Santa-Maria, D. M. Scholtens, S. Jain, L. Flaum, W. J. Gradishar, C. V. Clevenger, V. G. Kaklamani

03.07.2017 | Clinical trial | Ausgabe 3/2017 Open Access

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer

B. E. P. J. Vriens, I. J. H. Vriens, M. J. B. Aarts, S. M. van Gastel, F. W. P. J. van den Berkmortel, T. J. Smilde, L. J. C. van Warmerdam, D. J. van Spronsen, P. G. M. Peer, M. de Boer, V. C. G. Tjan-Heijnen, on behalf of the Breast Cancer Trialists’ Group of the Netherlands (BOOG)

05.07.2017 | Clinical trial | Ausgabe 3/2017

A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer

Hope S. Rugo, Olivier Trédan, Jungsil Ro, Serafin M. Morales, Mario Campone, Antonino Musolino, Noémia Afonso, Marta Ferreira, Kyong Hwa Park, Javier Cortes, Antoinette R. Tan, Joanne L. Blum, Lamar Eaton, Christine K. Gause, Zhen Wang, Ellie Im, David J. Mauro, Mary Beth Jones, Andrew Denker, José Baselga

06.07.2017 | Clinical trial | Ausgabe 3/2017

Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2− pN0 early breast cancers

Marie Viala, Marie Alexandre, Simon Thezenas, Pierre-Jean Lamy, Aurélie Maran-Gonzalez, Marian Gutowski, Pierre-Emmanuel Colombo, Gilles Romieu, William Jacot, Severine Guiu

22.06.2017 | Epidemiology | Ausgabe 3/2017

Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease

Rhonda Arthur, Yihong Wang, Kenny Ye, Andrew G. Glass, Mindy Ginsberg, Olivier Loudig, Thomas Rohan

22.06.2017 | Epidemiology | Ausgabe 3/2017

The effect of 14-3-3ζ expression on tamoxifen resistance and breast cancer recurrence: a Danish population-based study

Jake E. Thistle, Ylva Hellberg, Kristina Mortensen, Stephen Hamilton–Dutoit, Anders Kjærsgaard, Deirdre Cronin–Fenton, Henrik Toft Sørensen, Timothy L. Lash

22.06.2017 | Epidemiology | Ausgabe 3/2017 Open Access

Androgen receptor expression and breast cancer mortality in a population-based prospective cohort

Karin Elebro, Pär-Ola Bendahl, Helena Jernström, Signe Borgquist

22.06.2017 | Epidemiology | Ausgabe 3/2017

Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients

Daniel L. Hertz, Kelly A. Speth, Kelley M. Kidwell, Christina L. Gersch, Zeruesenay Desta, Anna Maria Storniolo, Vered Stearns, Todd C. Skaar, Daniel F. Hayes, N. Lynn Henry, James M. Rae

23.06.2017 | Epidemiology | Ausgabe 3/2017

Increasing utilization of regional nodal irradiation in elderly node-positive women and declining emphasis on demographic factors

Jason K. Molitoris, Tejan Diwanji, James W. Snider, Emily C. Bellavance, Susan B. Kesmodel, Paula Rosenblatt, Katherine Tkaczuk, Soren M. Bentzen, Randi J. Cohen, Elizabeth M. Nichols, Sally B. Cheston, Steven J. Feigenberg

26.06.2017 | Epidemiology | Ausgabe 3/2017

Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance)

Shirley M. Bluethmann, Catherine M. Alfano, Jonathan D. Clapp, George Luta, Brent J. Small, Arti Hurria, Harvey J. Cohen, Steven Sugarman, Hyman B. Muss, Claudine Isaacs, Jeanne S. Mandelblatt

29.06.2017 | Epidemiology | Ausgabe 3/2017

Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia

Xiaohong R. Yang, Beena C. R. Devi, Hyuna Sung, Jennifer Guida, Eliseos J. Mucaki, Yanzi Xiao, Ana Best, Lisa Garland, Yi Xie, Nan Hu, Maria Rodriguez-Herrera, Chaoyu Wang, Kristine Jones, Wen Luo, Belynda Hicks, Tieng Swee Tang, Karobi Moitra, Peter K. Rogan, Michael Dean

04.07.2017 | Epidemiology | Ausgabe 3/2017

The effects of physical activity and fatigue on cognitive performance in breast cancer survivors

Diane K. Ehlers, Susan Aguiñaga, Josh Cosman, Joan Severson, Arthur F. Kramer, Edward McAuley

04.07.2017 | Epidemiology | Ausgabe 3/2017 Open Access

Patterns and predictors of first and subsequent recurrence in women with early breast cancer

Y. M. Geurts, A. Witteveen, R. Bretveld, P. M. Poortmans, G. S. Sonke, L. J. A. Strobbe, S. Siesling

05.07.2017 | Epidemiology | Ausgabe 3/2017 Open Access

Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project

Hans-Jürgen Hurtz, Hans Tesch, Thomas Göhler, Ulrich Hutzschenreuter, Johanna Harde, Lisa Kruggel, Martina Jänicke, Norbert Marschner, TMK-Group (Tumour Registry Breast Cancer)

07.07.2017 | Epidemiology | Ausgabe 3/2017

Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer

Zhaomei Mu, Chun Wang, Zhong Ye, Giovanna Rossi, Carl Sun, Ling Li, Zhu Zhu, Hushan Yang, Massimo Cristofanilli

08.07.2017 | Epidemiology | Ausgabe 3/2017

Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors

Carol A. Parise, Vincent Caggiano

08.07.2017 | Epidemiology | Ausgabe 3/2017

Oncologists’ influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?

Steven J. Katz, Sarah T. Hawley, Irina Bondarenko, Reshma Jagsi, Kevin C. Ward, Timothy P. Hofer, Allison W. Kurian

24.06.2017 | Brief Report | Ausgabe 3/2017

Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast

Scott Kizy, Jing Li Huang, Schelomo Marmor, Todd M. Tuttle, Jane Yuet Ching Hui

27.06.2017 | Brief Report | Ausgabe 3/2017

Detection of BRCA1 gross rearrangements by droplet digital PCR

Elena V. Preobrazhenskaya, Ilya V. Bizin, Ekatherina Sh. Kuligina, Alla Yu. Shleykina, Evgeny N. Suspitsin, Olga A. Zaytseva, Elena I. Anisimova, Sergey A. Laptiev, Tatiana V. Gorodnova, Alexey M. Belyaev, Evgeny N. Imyanitov, Anna P. Sokolenko

30.06.2017 | Brief Report | Ausgabe 3/2017

From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancer

Hikmat Abdel-Razeq, Lina Marei, Salwa S. Saadeh, Hazem Abdulelah, Mahmoud Abu-Nasser, Mourad Salam, Walid Daana, Basel Al-Haj Ali, Ayat Taqash

03.07.2017 | Letter to the Editor | Ausgabe 3/2017

In response to “outcomes of patients with inflammatory breast cancer treated by breast conserving surgery”: the argument against breast conservation and sentinel lymph node biopsy in IBC

Kelly J. Rosso, Naoto T. Ueno, Wendy A. Woodward, Anthony Lucci

11.07.2017 | Rebuttal Letter | Ausgabe 3/2017

Response Letter

M. Brezezinska, L. J. Williams, J. Thomas, J. M. Dixon

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise